Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Life (Basel, Switzerland)|June 26, 2025
Differential Gene and Protein Expressions Responsible for Vasomotor Signaling Provide Mechanistic Bases for the Opposite Flow-Induced Responses of Pre- and Post-Circle of Willis ArteriesZoltan Nemeth, Krisztian Eros, Gyongyi Munkacsy, et al.
International Journal of Cardiology|July 10, 2016
PARP inhibition and postinfarction myocardial remodelingRobert Halmosi, Laszlo Deres, Roland Gal, et al.
Plos One|April 7, 2017
Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failureAdam Riba, Laszlo Deres, Krisztian Eros, et al.
Frontiers in Physiology|June 11, 2019
The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR RatsLaszlo Deres, Krisztian Eros, Orsolya Horvath, et al.
Frontiers in Physiology|May 29, 2019
PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma CellsAnna Maria Cseh, Zsolt Fabian, Ruben Quintana-Cabrera, et al.
Plos One|March 25, 2017
Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive ratsKrisztian Eros, Klara Magyar, Laszlo Deres, et al.
Free Radical Biology & Medicine|May 2, 2017
PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathwayEniko Hocsak, Viktor Szabo, Nikoletta Kalman, et al.
Plos One|July 12, 2014
PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoformsLaszlo Deres, Eva Bartha, Anita Palfi, et al.
Biochimica Et Biophysica Acta|March 25, 2014
A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive ratsKlara Magyar, Laszlo Deres, Krisztian Eros, et al.
Antioxidants (Basel, Switzerland)|November 14, 2020
Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart FailureRoland Gal, Laszlo Deres, Orsolya Horvath, et al.
Pageof 2